Compounds > 2-(n,n-dimethylamino)-6,7-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dimethylamino)-6,7-dihydroxytetralin and (3,4-dihydroxyphenylamino)-2-imidazoline

2-(n,n-dimethylamino)-6,7-dihydroxytetralin has been researched along with (3,4-dihydroxyphenylamino)-2-imidazoline in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Trials
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Studies
((3,4-dihydroxyphenylamino)-2-imidazoline)		Trials
((3,4-dihydroxyphenylamino)-2-imidazoline)		Recent Studies (post-2010) ((3,4-dihydroxyphenylamino)-2-imidazoline)
46006403

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horn, AS; Mulder, AH; Sminia, P; Van Oene, JC1

Other Studies

1 other study(ies) available for 2-(n,n-dimethylamino)-6,7-dihydroxytetralin and (3,4-dihydroxyphenylamino)-2-imidazoline

ArticleYear
The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitro.
    The Journal of pharmacy and pharmacology, 1983, Volume: 35, Issue:12

    Topics: Acetylcholine; Animals; Catecholamines; Cerebral Cortex; Corpus Striatum; Dopamine; Imidazolines; In Vitro Techniques; Male; Norepinephrine; Potassium; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Yohimbine

1983